Cathepsin X in serum from patients with colorectal cancer: relation to prognosis

Turk V, Kos J, Turk B. Cysteine cathepsins (proteases)-on the main stage of cancer? Cancer Cell 2004; 5: 409-10.10.1016/S1535-6108(04)00117-5Search in Google Scholar

Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.10.2478/v10019-008-0006-4Search in Google Scholar

Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.10.2478/v10019-011-0015-6342373122933943Search in Google Scholar

Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 1998; 5: 1349-61.10.3892/or.5.6.13499769367Search in Google Scholar

Kos J, Sekirnik A, Premzl A, Zavašnik Bergant V, Langerholc T, Turk B, et al. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp Cell Res 2005; 306: 103-13.10.1016/j.yexcr.2004.12.00615878337Search in Google Scholar

Kos J, Jevnikar Z, Obermajer N. The role of cathepsin X in cell signalling. Cell Adh Migr 2009; 3: 164-6.10.4161/cam.3.2.7403267987619262176Search in Google Scholar

Obermajer N, Jevnikar Z, Doljak B, Sadaghiani AM, Bogyo M, Kos J. Cathepsin X-mediated β2-integrin activation results in nanotube outgrowth. Cell Mol Life Sci 2009; 66: 1126-34.10.1007/s00018-009-8829-819194656Search in Google Scholar

Nascimento FD, Rizzi CC, Nantes IL, Stefe I, Turk B, Carmona AK, et al. Cathepsin X binds to cell surface heparan sulfate proteoglycans. Arch Biochem Biophys 2005; 436: 323-32.10.1016/j.abb.2005.01.01315797245Search in Google Scholar

Obermajer N, Repnik U, Jevnikar Z, Turk B, Kreft M, Kos J. Cysteine protease cathepsin X modulates immune response via activation of β2 integrins. Immunology 2008; 124: 76-88.10.1111/j.1365-2567.2007.02740.x243438418194276Search in Google Scholar

Obermajer N, Doljak B, Jamnik P, Fonovič UP, Kos J. Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells. Int J Biochem Cell Biol 2009; 41: 1685-96.10.1016/j.biocel.2009.02.01919433310Search in Google Scholar

Staudt DN, Aicher KW, Kalbacher H, Stevanovic S, Carmona KA, Bogyo M, et al. Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematol 2010; 95: 1452-60.10.3324/haematol.2009.018671293094420494937Search in Google Scholar

Krueger S, Kalinski T, Hundertmark T, Wex T, Küster D, Peitz U, et al. Upregulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol 2005; 207: 32-42.10.1002/path.182016025436Search in Google Scholar

Nägler DK, Lechner AM, Oettl A, Kozaczynska K, Scheuber HP, Gippner-Steppert C, et al. An enzyme-linked immunosorbent assay for human cathepsin X, a potential new inflamatory marker. J Immunol Methods 2006; 308: 241-50.10.1016/j.jim.2005.11.00216376371Search in Google Scholar

Baker AR, Zalwango S, Malone LL, Igo RP Jr, Qiu F, Nsereko M, et al. Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. Hum Immunol 2011; 72: 426-30.10.1016/j.humimm.2011.02.016307898621354459Search in Google Scholar

Ratovitski T, Chiqhladze E, Waldron E, Hirschhorn RR, Ross CA. Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J Biol Chem 2011; 286: 12578-89.10.1074/jbc.M110.185348306945921310951Search in Google Scholar

Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, et al. Differences in 20q13.2 Copy Number between Colorectal Cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-7.Search in Google Scholar

Bar-Shira A, Pinthus HJ, Rozovsky U, Goldstein M, Sellers RW, Yaron Y, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002; 62: 6803-7.Search in Google Scholar

Nägler DK, Krüger S, Kellner A, Ziomek E, Menard R, Buhtz P, et al. Upregulation of Cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate 2004; 60: 109-19.10.1002/pros.2004615162377Search in Google Scholar

Rumpler G, Becker B, Hafner C, McClelland M, Stolz W, Landthaler M, et al. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol 2003; 12: 761-71.10.1111/j.0906-6705.2003.00082.x14714555Search in Google Scholar

Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Müller S, et al. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. PNAS 2010; 107: 2497-502.10.1073/pnas.0907240107282391420133781Search in Google Scholar

Kraus S, Bunsen T, Schuster S, Cichoń MA, Tacke M, Reinheckel T, et al. Cellular senescence induced by cathepsin X downregulation. Eur J Cell Biol 2011; 90: 678-86.10.1016/j.ejcb.2011.03.00821616554Search in Google Scholar

Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers 2008; 23: 161-8.10.1177/172460080802300305Search in Google Scholar

Kolwijck E, Kos J, Obermajer N, Span PN, Thomas CM, Massuger LF, et al. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur J Clin Invest 2010; 40: 591-9.10.1111/j.1365-2362.2010.02305.x20482593Search in Google Scholar

Wang J, Chen L, Li Y, Guan XY. Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS ONE 2011; 6: e24967.10.1371/journal.pone.0024967317857821966391Search in Google Scholar

Fonovic PU, Kos J. Efficient removal of Cathepsin L from active Cathepsin X using immunoprecipitation technique. Acta Chim 2009; 56: 985-8.Search in Google Scholar

Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2011; doi: 10.1002/ijc.26192.10.1002/ijc.2619221607946Search in Google Scholar

Velenik V. Post-treatment surveillance in colorectal cancer. Radiol Oncol 2010, 44: 135-41.10.2478/v10019-010-0018-8342369922933905Search in Google Scholar

Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15: 5907-15.10.3748/wjg.15.5907279517720014454Search in Google Scholar

Booth RA. Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 2007; 249: 87-96.10.1016/j.canlet.2006.12.02117275174Search in Google Scholar

Nielsen HJ, Brünner N, Frederiksen C, Lomholt AF, King D, Jørgensen LN, et al. Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scand J Gastroenterol 2008; 43: 242-8.10.1080/0036552070152343918224568Search in Google Scholar

Nielsen HJ, Christensen IJ, Brünner N. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1. Scand J Gastroenterol 2010; 45: 200-7.10.3109/0036552090342940620095885Search in Google Scholar

Obermajer N, Premzl A, Zavašnik Bergant T, Turk B, Kos J. Carboxypeptidase cathepsin X mediates β2-integrin-dependent adhesion of differentiated U-937 cells. Exp Cell Res 2006; 312: 2515-27.10.1016/j.yexcr.2006.04.01916774752Search in Google Scholar

Nägler DK, Zhang R, Tam W, Sulea T, Purisima EO, Ménard R. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry 1999; 38: 12648-54.10.1021/bi991371z10504234Search in Google Scholar

Vasiljeva O, Papazoglou A, Krüger A, Brodoefel H, Korovin M, Deussing J, et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 2006; 66: 5242-50.10.1158/0008-5472.CAN-05-4463Search in Google Scholar

Lines KE, Chelala C, Dmitrovic B, Wijesuriya N, Kocher HM, Marshall JF, et al. S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Am J Pathol 2012; 180: 1485-94.10.1016/j.ajpath.2011.12.031Search in Google Scholar

Nägler DK, Mènard R: Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett 1998; 434: 135-9.10.1016/S0014-5793(98)00964-8Search in Google Scholar

Santamaría I, Velasco G, Pendás AM, Fueyo A, López-Otín C. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and unique chromosomal location. J Biol Chem 1998; 273: 16816-23.10.1074/jbc.273.27.168169642240Search in Google Scholar

Hafner A, Obermajer N, Kos J. γ-1-syntrophin mediates trafficking of γ-enolase towards the plasma membrane and enhances its neurotrophic activity. Neurosignals 2010; 18: 246-58.10.1159/00032429221358174Search in Google Scholar

Hafner A, Obermajer N, Kos J. γ-Enolase C-terminal peptide promotes cell survival and neurite ougrowth by activation of PI3K/Akt and MAPK/ERK signalling pathways. Biochem J 2012; 443: 439-50.10.1042/BJ2011135122257123Search in Google Scholar